Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Klin Lab Diagn ; (1): 35-8, 2011 Jan.
Artigo em Russo | MEDLINE | ID: mdl-21433317

RESUMO

The frequency of AB0 blood groups was analyzed in donors and cancer patients. Blood group A(II) was found to be more common in patients with cancers at various sites. Blood groups 0(I) (35.9%) and A(II) (35.6%) were most common in donors. This seems to be linked with that the subjects with blood group 0(I) are actively involved in donation. The study allow conclusion that it is expedient to incorporate blood samples from cancer inpatients into an immunohematological assay for antigen A variants.


Assuntos
Sistema ABO de Grupos Sanguíneos/sangue , Doadores de Sangue , Neoplasias/sangue , Tipagem e Reações Cruzadas Sanguíneas/métodos , Feminino , Humanos , Masculino , Neoplasias/epidemiologia
3.
Ter Arkh ; 70(7): 67-9, 1998.
Artigo em Russo | MEDLINE | ID: mdl-9742642

RESUMO

AIM: Analysis of transplantations of allogenic bone marrow (BM) for determination of transfusiological problems arising in various types of donor's and recipient's blood ABO incompatibility. MATERIALS AND METHODS: 46 allogenic BM transplantations from relative donors are analysed. The following types of ABO incompatibility were identified: significant (12 donor-recipient pairs), insignificant (10 pairs), combined (2 pairs). RESULTS: The proposed methods of BM fractionation provided the yield of nucleated cells in minimal admixture of red cells. This allowed to minimize loss of stem cells at fractionation and to prevent acute hemolysis at infusion of BM suspension in cases of ABO group-different BM allotransplantations. CONCLUSION: The proposed modification of the "shelf" method enabled effective fractionation of small BM volumes obtained from children-BM donors with high yield of nucleated cells and small admixture of incompatible red cells. Reinfusion of erythrocytic mass obtained at fractionation of donor BM fractionation used as replacement therapy makes allogenic blood transfusion unnecessary in 66% of BM donors.


Assuntos
Transplante de Medula Óssea , Transfusão de Eritrócitos , Sistema ABO de Grupos Sanguíneos/imunologia , Transplante de Medula Óssea/imunologia , Transplante de Medula Óssea/métodos , Criança , Transfusão de Eritrócitos/métodos , Antígenos HLA/imunologia , Hemólise/imunologia , Teste de Histocompatibilidade , Humanos , Transplante Homólogo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...